Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 4 boards, counting each seat separately. Longest: Natera Inc., 3 years.
Natera Inc.
Director
Travere Therapeutics Inc.
Director
Aardvark Therapeutics Inc.
Director
Nurix Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Natera Inc. June 12, 202580.9%
-
Nurix Therapeutics Inc. May 19, 202599.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2026 | Natera Inc. | Grant or award | +1,571 | — | — |
| Jun 26, 2026 | Natera Inc. | Grant or award | +75 | — | — |
| Jun 12, 2026 | Travere Therapeutics Inc. | Option exercise | +4,500 | $21.38 | $96,210 |
| Jun 12, 2026 | Travere Therapeutics Inc. | Open-market sale | −4,500 | $50.00 | $225,000 |
| May 19, 2026 | Travere Therapeutics Inc. | Grant or award | +4,000 | — | — |
| May 5, 2026 | Travere Therapeutics Inc. | Option exercise | +4,500 | $18.27 | $82,215 |
| May 5, 2026 | Travere Therapeutics Inc. | Open-market sale | −4,500 | $46.65 | $209,925 |
| May 1, 2026 | Travere Therapeutics Inc. | Option exercise | +9,750 | $6.82 | $66,495 |
| May 1, 2026 | Travere Therapeutics Inc. | Open-market sale | −9,750 | $44.22 | $431,145 |
| Apr 24, 2026 | Natera Inc. | Grant or award | +83 | — | — |
| Apr 14, 2026 | Travere Therapeutics Inc. | Option exercise | +8,000 | $17.94 | $143,520 |
| Apr 14, 2026 | Travere Therapeutics Inc. | Option exercise | +9,000 | $15.43 | $138,870 |
| Apr 14, 2026 | Travere Therapeutics Inc. | Option exercise | +4,500 | $18.27 | $82,215 |
| Apr 14, 2026 | Travere Therapeutics Inc. | Option exercise | +4,500 | $21.38 | $96,210 |
| Apr 14, 2026 | Travere Therapeutics Inc. | Option exercise | +6,750 | $17.11 | $115,493 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.